3,4-methylenedioxyamphetamine has been researched along with Child Development Disorders, Pervasive in 2 studies
3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.
Child Development Disorders, Pervasive: Severe distortions in the development of many basic psychological functions that are not normal for any stage in development. These distortions are manifested in sustained social impairment, speech abnormalities, and peculiar motor movements.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shumaker, L | 1 |
| Cornell, C | 1 |
2 other studies available for 3,4-methylenedioxyamphetamine and Child Development Disorders, Pervasive
| Article | Year |
|---|---|
Love, autism style.
Topics: Child Development Disorders, Pervasive; Courtship; Disability Evaluation; Family Relations; Humans; | 2012 |
Transition years: from learning, living and loving to maintenance and mediocrity.
Topics: Adaptation, Psychological; Aging; Caregivers; Child Development Disorders, Pervasive; Empathy; Femal | 2012 |